Effects of a 10-Week Zumba Program on Adiposity and Flexibility in 8-Year-Old Children

March 30, 2026 updated by: Aysen CALIKUSU, Ege University

GENDER-SPESIFIC EFFECTS OF A 10-WEEK ZUMBA DANCE-BASED EXERCISE PROGRAM ON PEDIATRIC ADIPOSITY AND FLEXIBILITY IN HEALTHY 8-YEAR-OLD CHILDREN: A PROSPECTIVE INTERVENTION STUDY

The purpose of this study is to investigate the effects of a 10-week Zumba dance-based exercise program on body fat (adiposity) and flexibility in healthy 8-year-old children. The study also aims to explore if these effects differ between boys and girls. Participants will take part in a 10-week Zumba exercise program. Researchers will measure the children's body composition (body fat percentage) and physical fitness (flexibility and abdominal endurance) before the program begins (baseline) and immediately after the 10-week intervention is completed.

Study Overview

Status

Completed

Detailed Description

Childhood obesity and physical inactivity are growing global health concerns. Engaging children in enjoyable physical activities is crucial for their physical development and overall health. Zumba, a dance-based exercise, offers a fun and rhythmic alternative to traditional exercises, which may increase participation and adherence among children.

This prospective intervention study aims to evaluate the gender-specific effects of a 10-week Zumba dance-based exercise program on pediatric adiposity and flexibility. Healthy 8-year-old children will participate in a structured Zumba program (consisting of 40-minute sessions, 3 days a week) for 10 weeks. Anthropometric measurements (to assess adiposity via body fat percentage) and physical fitness tests (including the sit-and-reach test for flexibility and sit-up test for abdominal endurance) are conducted at baseline and after the 10-week intervention. The findings will help determine the effectiveness of Zumba as a school-based or extracurricular physical activity intervention for improving body composition and physical fitness in prepubertal children.

Study Type

Interventional

Enrollment (Actual)

115

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Healthy children aged exactly 8 years.

Voluntary participation with signed written informed consent from parents or legal guardians.

Ability to understand and follow basic exercise instructions.

Exclusion Criteria:

Any physical, orthopedic, or neurological disability that would prevent participation in a dance-based exercise program.

Diagnosis of any chronic metabolic, cardiovascular, or respiratory disease.

Regular participation in other structured sports or dance programs outside of the school curriculum during the study period.

Missing more than 20% of the total Zumba sessions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Zumba Exercise Group
Healthy 8-year-old children participating in a 10-week Zumba dance-based exercise program.
A 10-week structured Zumba program consisting of 40-minute sessions, conducted 3 days a week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Adiposity (Body Fat Percentage)
Time Frame: Baseline (Week 0) and immediately after the 10-week intervention (Week 10)
Adiposity will be evaluated by measuring the children's body fat percentage using standard anthropometric methods.
Baseline (Week 0) and immediately after the 10-week intervention (Week 10)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Flexibility
Time Frame: Baseline (Week 0) and immediately after the 10-week intervention (Week 10)
Flexibility will be measured using the standard sit-and-reach test.
Baseline (Week 0) and immediately after the 10-week intervention (Week 10)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: AYŞEN ÇALIKUŞU, PHD, Ege University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2023

Primary Completion (Actual)

March 10, 2023

Study Completion (Actual)

March 10, 2023

Study Registration Dates

First Submitted

March 30, 2026

First Submitted That Met QC Criteria

March 30, 2026

First Posted (Actual)

April 6, 2026

Study Record Updates

Last Update Posted (Actual)

April 6, 2026

Last Update Submitted That Met QC Criteria

March 30, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified individual participant data that underlie the results reported in this article will be shared.

IPD Sharing Time Frame

Data will be available immediately following the publication of the article and will be accessible for a period of 5 years.

IPD Sharing Access Criteria

Data will be shared with researchers who provide a methodologically sound proposal. Proposals should be directed to the corresponding author via email. To gain access, data requestors will need to sign a data access agreement.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adiposity

Clinical Trials on Zumba Dance-Based Exercise Program

Subscribe